StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Co-Diagnostics's market cap was $1.36M on Nov 11, 2026, against $17.84M a year earlier. Over the last 5 years it ranged from $1.36M to $258.03M, with a median of $35.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.36M-83.3%
2025Dec 31, 2025$8.12M-66.1%
2024Dec 31, 2024$23.95M-41.3%
2023Dec 29, 2023$40.78M-47.7%
2022Dec 30, 2022$77.91M-69.8%
2021Dec 31, 2021$258.03M-1.5%
2020Dec 31, 2020$261.90M+1578.5%
2019Dec 31, 2019$15.60M-17.3%
2018Dec 31, 2018$18.87M-41.8%
2017Dec 29, 2017$32.43M–

More Co-Diagnostics figures

See a number that looks wrong?